Expression of phosphorylated epidermal growth factor receptor (p-EGFR) in early stage non-small cell lung cancer: its relationship with overexpression of EGFR and cyclooxygenase-2 (COX-2), and survival
Publication
, Conference
Kim, SJ; Rabbani, ZN; Vollmer, RT; Schreiber, EG; Dewhirst, MW; Vujaskovic, Z; Kelley, MJ
Published in: JOURNAL OF CLINICAL ONCOLOGY
June 1, 2005
Duke Scholars
Published In
JOURNAL OF CLINICAL ONCOLOGY
EISSN
1527-7755
ISSN
0732-183X
Publication Date
June 1, 2005
Volume
23
Issue
16
Start / End Page
864S / 864S
Location
Orlando, FL
Publisher
AMER SOC CLINICAL ONCOLOGY
Conference Name
41st Annual Meeting of the American-Society-of-Clinical-Oncology
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Kim, S. J., Rabbani, Z. N., Vollmer, R. T., Schreiber, E. G., Dewhirst, M. W., Vujaskovic, Z., & Kelley, M. J. (2005). Expression of phosphorylated epidermal growth factor receptor (p-EGFR) in early stage non-small cell lung cancer: its relationship with overexpression of EGFR and cyclooxygenase-2 (COX-2), and survival. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 23, pp. 864S-864S). Orlando, FL: AMER SOC CLINICAL ONCOLOGY.
Kim, S. J., Z. N. Rabbani, R. T. Vollmer, E. G. Schreiber, M. W. Dewhirst, Z. Vujaskovic, and M. J. Kelley. “Expression of phosphorylated epidermal growth factor receptor (p-EGFR) in early stage non-small cell lung cancer: its relationship with overexpression of EGFR and cyclooxygenase-2 (COX-2), and survival.” In JOURNAL OF CLINICAL ONCOLOGY, 23:864S-864S. AMER SOC CLINICAL ONCOLOGY, 2005.
Kim SJ, Rabbani ZN, Vollmer RT, Schreiber EG, Dewhirst MW, Vujaskovic Z, et al. Expression of phosphorylated epidermal growth factor receptor (p-EGFR) in early stage non-small cell lung cancer: its relationship with overexpression of EGFR and cyclooxygenase-2 (COX-2), and survival. In: JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY; 2005. p. 864S-864S.
Kim, S. J., et al. “Expression of phosphorylated epidermal growth factor receptor (p-EGFR) in early stage non-small cell lung cancer: its relationship with overexpression of EGFR and cyclooxygenase-2 (COX-2), and survival.” JOURNAL OF CLINICAL ONCOLOGY, vol. 23, no. 16, AMER SOC CLINICAL ONCOLOGY, 2005, pp. 864S-864S.
Kim SJ, Rabbani ZN, Vollmer RT, Schreiber EG, Dewhirst MW, Vujaskovic Z, Kelley MJ. Expression of phosphorylated epidermal growth factor receptor (p-EGFR) in early stage non-small cell lung cancer: its relationship with overexpression of EGFR and cyclooxygenase-2 (COX-2), and survival. JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY; 2005. p. 864S-864S.
Published In
JOURNAL OF CLINICAL ONCOLOGY
EISSN
1527-7755
ISSN
0732-183X
Publication Date
June 1, 2005
Volume
23
Issue
16
Start / End Page
864S / 864S
Location
Orlando, FL
Publisher
AMER SOC CLINICAL ONCOLOGY
Conference Name
41st Annual Meeting of the American-Society-of-Clinical-Oncology
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences